Trial Profile
Retrospective study of strontium ranelate in older patients to study Cardiovascular and mortality risk
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Strontium ranelate (Primary)
- Indications Osteoporosis
- Focus Adverse reactions
- 07 Dec 2015 New trial record